Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Roman Dbdr Acquisition Ii's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Roman Dbdr Acquisition Ii (DRDB) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/DRDB/competitors
https://api.csimarket.com/api/v1/companies/DRDB/relationships
https://api.csimarket.com/api/v1/companies/DRDB/similar
Programmatic access for models, analytics, and integration workflows.

Roman Dbdr Acquisition Ii's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Roman Dbdr Acquisition Corp Ii - - - Yes
High-Confidence Competitors (1) 0% 0% 0% 0%
Similar-Size Competitors (10) - - - 100%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

DRDB Stock Performance relative to its Competitors

DRDB Competitors (weighted) Percent change over the selected range

Roman Dbdr Acquisition Ii's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
High-Confidence
(0 of 1)
0%beat U.S.A. 500
Similar-Size
(0 of 2)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Roman Dbdr Acquisition Corp Ii 4.00 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (1) 40.4% 63.2%
Similar-Size Competitors (2) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Roman Dbdr Acquisition Ii's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

DRDB Stock Performance relative to High-Confidence Competitors

DRDB High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

DRDB Stock Performance relative to Similar-Size Competitors

DRDB Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Roman Dbdr Acquisition Ii's Comment on Competition and Industry Peers

The company faces competition in pursuing its initial Business Combination, including the ThomasLloyd Business Combination, from various entities with similar objectives. These competitors include other SPACs, private equity groups, leveraged buyout funds, public companies, and operating businesses seeking strategic acquisitions. Many competitors are well established with extensive experience and possess financial, technical, human, and other resources comparable to or exceeding those of the company. The company's financial resources limit its ability to acquire larger target businesses, potentially giving competitors an advantage. Additionally, obligations to pay cash to Public Shareholders exercising redemption rights and potential dilution from issued Warrants may be viewed unfavorably by target businesses. Competitors named in filings include ThomasLloyd.
Competitor data is not yet available for Roman Dbdr Acquisition Ii.

Roman Dbdr Acquisition Ii's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
ThomasLloyd Named by the company 85% 2022 to 2026 3
Mangoceuticals Inc Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Roman Dbdr Acquisition Ii's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API License